News
News
TomoTherapy and Novation annouced agreement for Radiation Therapy Equipment
TomoTherapy Incorporated , maker of the Hi·Art® treatment system for advanced radiation therapy, announced that it has signed a supply agreement with Novation, the health care contracting services company of VHA Inc., the University HealthSystem Consortium and Provista, LLC....
News
Cook Medical announced the launch of Advance® 18LP PTA Balloon Dilatation Catheter
Cook Medical announced today the North American launch of its Advance® 18LP Balloon Dilatation Catheter. With a low crossing profile and small sheath compatibility, Advance 18LP is designed to provide physicians with superior deliverability. Cook Medical announced...
News
Wockhardt gets US FDA nod to market Ceftazidime injections
Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for marketing the injections containing 1 Gm/Vial Ceftazidime, which is used for treating various kinds of infections. Ceftazidime is the generic name for the brand...
News
Zimmer holdings announced the acquisition of Abbott Spine
Zimmer Holdings, Inc. that its acquisition of Abbott Spine has been completed. Zimmer paid $360 million in cash in the transaction. Zimmer Holdings, Inc. that its acquisition of Abbott Spine has been completed. Zimmer paid $360 million in...
News
Covidien introduces Plus Bladeless Trocar line for the minimally invasive surgical market
Covidien, a leading global provider of healthcare products, announced that its Surgical Devices business unit has launched the Versaport(TM) Plus Bladeless Trocar line for the minimally invasive surgical market worldwide. Covidien, a leading global provider of healthcare products,...
News
Integra announced launch of light source for use in surgical procedures
Integra LifeSciences Holdings Corporation announced the introduction of the Luxtec(R) MLX 300W Xenon light source for use in surgical procedures, the latest addition to Luxtec's extensive line of illumination systems. Integra LifeSciences Holdings Corporation announced the introduction...
News
W. L. Gore receives FDA approval for Gore EMBOLDEN Clinical Study
W. L. Gore & Associates announced full approval from the US Food and Drug Administration for the Gore EMBOLDEN Clinical Study. The Gore EMBOLDEN Clinical Study is a prospective, multi-center, non-randomized, single-arm study designed to evaluate the safety and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
